RIPK1 and alkaline phosphatase measurement: Previously, our results suggested that the inhibition of RIPK1-dependent regulated necrosis provided protection against AP via the RIPK1/NF-κB/aquaporin (AQP) 8 pathway, indicating a new horizon for exploring the mechanism of AP and its possible targeted therapy [5].